KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for Neogenomics (NEO) over the last 17 years, with Sep 2025 value amounting to $129.2 million.

  • Neogenomics' Shares Outstanding (Weighted Average) rose 0.80% to $129.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.2 million, marking a year-over-year increase of 0.80%. This contributed to the annual value of $128.4 million for FY2024, which is 0.70% up from last year.
  • According to the latest figures from Q3 2025, Neogenomics' Shares Outstanding (Weighted Average) is $129.2 million, which was up 0.38% from $128.7 million recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Shares Outstanding (Weighted Average) registered a high of $129.2 million during Q3 2025, and its lowest value of $116.9 million during Q1 2021.
  • For the 3-year period, Neogenomics' Shares Outstanding (Weighted Average) averaged around $128.0 million, with its median value being $127.7 million (2024).
  • Data for Neogenomics' Shares Outstanding (Weighted Average) shows a peak YoY climbed of 11.95% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Neogenomics' Shares Outstanding (Weighted Average) stood at $123.1 million in 2021, then rose by 2.58% to $126.3 million in 2022, then climbed by 0.92% to $127.5 million in 2023, then rose by 0.70% to $128.4 million in 2024, then climbed by 0.80% to $129.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $129.2 million in Q3 2025, compared to $128.7 million in Q2 2025 and $128.5 million in Q1 2025.